CatalystPit

BSEMBioStem Technologies, Inc.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $2.47 · 2026-10-09
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$55.15M
CountryUSA
RECENT INSIDER TRADES
  • 2026-10-09 · SMITH-VAN VURST ANDREW (Chief Operating Officer) · OTHER
  • 2026-10-09 · Matuszewski Jason (Chief Executive Officer) · OTHER
  • 2026-09-17 · Matuszewski Jason (Chief Executive Officer) · OTHER
  • 2026-09-17 · SMITH-VAN VURST ANDREW (Chief Operating Officer) · OTHER
RECENT NEWS
  • BioStem Technologies’ CEO and COO Invest $1 Million in Cash Through Exercise of Stock Options
  • BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio
  • BioStem Technologies announces $3M offering
  • BioStem Technologies joins Terminal1 platform
  • BioStem Technologies secures $40M equity facility with Roth
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS